ArticleBMC complementary medicine and therapies2025
Antioxidant, urobactericidal and antibiotic modulating activity of the methanolic extract of the stem and resin of Acacia catechu (L.f.) Willd.
Article in BMC complementary medicine and therapies, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Anti-inflammatory and anti-bacterial potentials of Caryota mitis L. leaves extract in urothelial LPS-induced inflammation and UTI pathogens.Archives of microbiology · 2026Article
- Chemical composition, antioxidant and antimicrobial activities, and molecular docking of Acacia gerrardii leaf extract.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEmergence of multidrug resistant pathogens has opened new vistas for novel drug discovery or combinatorial drug surveillance, often in form of some natural products, which is considered to be cheap and safe. In this study, the urobactericidal activity of the methanolic extract of the stem and resin of Acacia catechu (L.f.) Willd (Fabaceae) was explored against five uropathogenic bacterial strains i.e. Escherichia coli, Enterococcus faecalis, Pseudomonas aeruginosa, Proteus vulgaris and Staphylococcus aureus.
methodsVarieties of antibacterial (disc diffusion, agar well diffusion, modified agar well diffusion) and antioxidant assays (DPPH and OH free radical scavenging assay) were tried to prove the efficacy of stem and resin extracts of A. catechu and to compare their urobactericidal and free radical scavenging properties.
resultsPhytochemical analysis envisaged that the stem and resin contained phytoconstituents like alkaloids, phenols, tannins, proteins, glycosides, flavonoids, steroids and terpenoids, which were reported to have excellent antioxidant and antibacterial activities. The total phenolic contents of the methanolic extract of A. catechu stem (ACs) and A. catechu resin (ACr) were calculated as 37.74 ± 0.023 and 51.98 ± 0.011 mg/g Gallic Acid equivalents. The total flavonoid contents of methanolic extract of ACs and ACr were calculated to be 71.33 ± 0.004 and119.6 ± 0.010 mg/g Rutin equivalent. ACs had IC
conclusionOur results indicated the excellent urobactericidal effects of the stem and resin extracts of a least explored natural remedy against uropathogens, which will be beneficial for treating urinary tract infections and augmenting the quest for novel therapies in future for uropathogenesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.